A new anti-inflammatory compound, FR167653, ameliorates crescentic glomerulonephritis in Wistar-Kyoto rats

Journal of the American Society of Nephrology

Volumn 11, Issue 8, 2000, Pages 1534-1541

  Wada, Takashi ^a   Furuichi, Kengo ^a   Sakai, Norihiko ^a   Iwata, Yasunori ^a   Yoshimoto, Keiichi ^a   Shimizu, Miho ^a   Kobayashi, Ken Ichi ^a   Mukaida, Naofumi ^b   Matsushima, Kouji ^c   Yokoyama, Hitoshi ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 [7 (4 FLUOROPHENYL) 1,2,3,4 TETRAHYDRO 8 (4 PYRIDYL)PYRAZOLO[5,1 C][1,2,4]TRIAZIN 2 YL] 2 PHENYLETHANEDIONE; ANTIINFLAMMATORY AGENT; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG PROTEIN BINDING; GLOMERULONEPHRITIS; HISTOPATHOLOGY; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; URINARY EXCRETION;

EID: 0033943627     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/asn.v1181534     Document Type: Article

References (29)

1. Wada T, Yokoyama H, Furuichi K, Kobayashi K, Harada K, Naruto M, Su SB, Akiyama M, Mukaida N, Matsushima K: Intervention of crescentic glomerulonephritis by antibodies to monocyte chemotactic and activating factor (MCAF/MCP-1). FASEB J 10: 1418-1425, 1996
2. Schena FP, Gesualdo L, Grandalliano G, Montinaro V: Progression of renal damage in human glomerulonephritides: Is there sleight of hand in winning the game? Kidney Int 52: 1439-1457, 1997
3. Lan HY, Nikolic-Paterson DJ, Zarama M, Vannice JL, Atkins RC: Suppression of experimental crescentic glomerulonephritis by the IL-1 receptor antagonist. Kidney Int 43: 479-485, 1993
4. Tang WW, Feng L, Vannice JL, Wilson CB: Interleukin-1 receptor antagonist ameliorates experimental anti-glomerular basement membrane antibody-associated glomerulonephritis. J Clin Invest 93: 273-279, 1994
5. Karkar AM, Tam FW, Steinkasserer A, Kurrle R, Langer K, Scallon BJ, Meager A, Rees AJ: Modulation of antibody-mediated glomerular injury in vivo by IL-1ra, soluble IL-1 receptor, and soluble TNF-α receptor. Kidney Int 48: 1738-1746, 1995
6. Fujinaka H, Yamamoto T, Feng L, Kawasaki K, Yaoita E, Hirose S, Goto S, Wilson CB, Uchiyama M, Kihara I: Crucial role of CD8-positive lymphocytes in glomerular expression of ICAM-1 and cytokines in crescentic glomerulonephritis of WKY rats. J Immunol 158: 4978-4983, 1997
7. Yokoyama H, Takaeda M, Wada T, Ohta S, Hisada Y, Segawa C, Furuichi K, Kobayashi K: Glomerular ICAM-1 expression related to circulating TNF-α in human glomerulonephritis. Nephron 76: 425-433, 1997
8. Mukaida N, Harada A, Matsushima K: Interleukin-8 (IL-8) and monocyte chemotactic and activating factor (MCAF/MCP-1), chemokines essentially involved in inflammatory and immune reactions. Cytokine Growth Factor Rev 9: 9-23, 1998
9. Yokoyama H, Wada T, Furuichi K, Segawa C, Shimizu M, Kobayashi K, Su SB, Mukaida N, Matsushima K: Urinary levels of chemokines (MCAF/MCP-1, IL-8) reflect distinct disease activities and phases of human IgA nephropathy. J Leukocyte Biol 63: 493-499, 1998
10. Wada T, Yokoyama H, Su SB, Mukaida N, Iwano M, Dohi K, Takahashi Y, Sasaki T, Furuichi K, Segawa C, Hisada Y, Ohta S, Takasawa K, Kobayashi K, Matsushima K: Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritis. Kidney Int 49: 761-767, 1996
11. Wada T, Furuichi K, Segawa C, Shimizu M, Sakai N, Takeda S, Takasawa K, Kida H, Kobayashi K, Mukaida N, Ohmoto Y, Matsushima K, Yokoyama H: MIP-1α and MCP-1 contribute to crescents and interstitial lesions in human crescentic glomerulonephritis. Kidney Int 56: 995-1003, 1999
12. Le Hir M, Haas C, Marino M, Ryffel B: Prevention of crescentic glomerulonephritis induced by anti-glomerular membrane anti-body in tumor necrosis factor-deficient mice. Lab Invest 78: 1625-1631, 1998
13. Yamamoto N, Sakai F, Yamazaki H, Nakahara K, Okuhara M: Effect of FR167653, a cytokine suppressive agent, on endotoxin-induced disseminated intravascular coagulation. Eur J Pharmacol 314: 137-142, 1996
14. Yamamoto N, Sakai F, Yamazaki H, Sato N, Nakahara K, Okuhara M: FR167653, a dual inhibitor of interleukin-1 and tumor necrosis factor-α, ameliorates endotoxin-induced shock. Eur J Pharmacol 327: 169-175, 1997
15. Kobayashi J, Takeyoshi I, Ohwada S, Iwanami K, Matsumoto K, Muramoto M, Morishita Y: The effects of FR167653 in extended liver resection with ischemia in dogs. Hepatology 28: 459-465, 1998
16. 2 and inflammatory cytokines, human monocytes, and alveolar macrophages in response to endotoxin. J Leukocyte Biol 65: 80-86, 1999
17. Krakower C, Greenspon SA: Localization of nephrotoxic antigen within the isolated renal glomerulus. Arch Pathol 51: 629-639, 1951
18. Wada T, Tomosugi N, Naito T, Yokoyama H, Kobayashi K, Mukaida N, Matsushima K: Prevention of proteinuria by the administration of anti-interleukin 8 antibody in experimental acute immune complex-induced glomerulonephritis. J Exp Med 180: 1135-1140, 1994
19. Wada T, Schwarting A, Kinoshita K, Naito T, Griffiths RC, Coffman TM, Kelley VR: Fas on renal parenchymal cells does not promote autoimmune nephritis in MRL mice. Kidney Int 55: 841-851, 1999
20. Natori Y, Sekiguchi M, Ou Z, Natori Y: Gene expression of CC chemokines in experimental crescentic glomerulonephritis (CGN). Clin Exp Immunol 109: 143-148, 1997
21. Nathan CF: Secretary products of macrophages. J Clin Invest 79: 319-326, 1987
22. lpr mice. Kidney Int 53: 1631-1638, 1998
23. Luster AD: Chemokine-chemotactic cytokines that mediate inflammation. N Engl J Med 338: 436-445, 1998
24. Tomosoni S, Noris M, Zappella S, Gotti E, Casiraghi F, Bonazzola S, Benigni A, Remuzzi G: Upregulation of renal systemic cyclooxygenase-2 in patients with active lupus nephritis. J Am Soc Nephrol 9: 1202-1212, 1998
25. 2 synthetase inhibitor, DP-1904, in lupus nephritis. J Rheumatol 23: 1719-1724, 1996
26. Schneider A, Harendza S, Zahner G, Jocks T, Wenzel U, Wolf G, Thaiss F, Helmchen U, Stahl RA: Cyclooxygenase metabolites mediate glomerular monocyte chemoattractant protein-1 formation and monocyte recruitment in experimental glomerulonephritis. Kidney Int 55: 430-441, 1999
27. Yamada T, Murase M, Maeda T, Ye Q, Sakamoto T, Terakura M, Starzl TE, Todo S: Protective effect of TNF-α and IL-1β inhibitor FR167653 on ischemia-reperfusion injury in rat small intestinal transplantation [Abstract]. Transplant Proc 30: 2638, 1998
28. Gardiner SM, Kemp PA, Maech JE, Bennett T: Influence of FR167653, an inhibitor of TNF-α and IL-1, on the cardiovascular responses to chronic infusion of lipopolysaccharide in conscious rats. J Cardiovasc Pharmacol 34: 64-69, 1999
29. Konaka A, Nishijima M, Tanaka A, Kunikata T, Kato S, Takeuchi K: Nitric oxide, Superoxide radicals and mast cells in pathogenesis of indomethacin-induced small intestinal lesions in rats. J Physiol Pharmacol 50: 25-38, 1999